ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMRN Amarin Corp PLC

1.19
0.01 (0.85%)
Feb 24 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Amarin Corp PLC AMRN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.01 0.85% 1.19 00:00:04
Open Price Low Price High Price Close Price Prev Close
1.18 1.16 1.20 1.19 1.18
more quote information »

Recent News

Date Time Source Heading
2/15/202408:00GLOBEAmarin to Report Fourth Quarter and Full Year 2023 Financial..
2/12/202408:00EDGAR2Form PRE 14A - Other preliminary proxy statements
2/09/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/26/202407:00EDGAR2Form 8-K - Current report
1/24/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/22/202407:30GLOBEAmarin Chairman & CEO Issue Letter to Shareholders
1/12/202417:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/12/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/12/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/10/202407:00EDGAR2Form 8-K - Current report
1/10/202407:00GLOBEAmarin Provides Preliminary Fourth Quarter 2023 Selected..
1/08/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202416:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202416:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/14/202318:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202316:20EDGAR2Form 144 - Report of proposed sale of securities
12/11/202308:00GLOBEAmarin to Present at the 42nd Annual J.P. Morgan Healthcare..
12/05/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/05/202307:30EDGAR2Form SC 13D/A - General statement of acquisition of..
11/12/202309:00GLOBENew REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl)..
11/03/202316:30EDGAR2Form 8-K - Current report
11/01/202307:05EDGAR2Form 8-K - Current report
11/01/202307:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/202307:00GLOBEAmarin Reports Third Quarter 2023 Financial Results
10/31/202316:05EDGAR2Form 8-K - Current report
10/31/202312:00GLOBEAmarin Appoints Jonathan Provoost Executive Vice President,..
10/26/202308:00GLOBELatest Research Evaluating VASCEPA®/VAZKEPA® (icosapent..
10/19/202308:00GLOBE Amarin to Report Third Quarter 2023 Financial Results and..
9/12/202308:00GLOBEAmarin to Present at the 2023 Cantor Global Healthcare..
9/05/202316:15EDGAR2Form SC 13D/A - General statement of acquisition of..
8/16/202319:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/16/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/09/202316:05GLOBEAmarin Provides Pricing & Reimbursement Updates for VAZKEPA..
8/08/202307:00GLOBEAmarin And Neopharm Announce Exclusive Commercialization..
8/07/202307:00GLOBEScottish Medicines Consortium Accepts VAZKEPA® (icosapent..
8/02/202317:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/02/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/02/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/02/202308:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
8/02/202308:34EDGAR2Form S-3 - Registration statement under Securities Act of..
8/02/202307:11GLOBEAmarin Reports Second Quarter 2023 Financial Results
8/02/202307:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/02/202307:01EDGAR2Form 8-K - Current report
7/31/202308:00GLOBEAmarin and Lotus Pharmaceuticals Announce Exclusive..

Your Recent History

Delayed Upgrade Clock